MLYS vs MSFT: Which Stock is Better?

Side-by-side comparison of Mineralys Therapeutics, Inc. Common Stock and Microsoft Corp in 2026

Comparison Updated:

MLYS

Mineralys Therapeutics, Inc. Common Stock

$31.93

MSFT

Microsoft Corp

$454.79

Key Metrics Comparison

MetricMLYSMSFTWinner
Market Cap$2.53B$3.38TMSFT
P/E RatioN/A36.30MSFT
EPS (TTM)$N/A$13.70MSFT
Revenue Growth0.0%14.9%MSFT
Gross Margin0.0%68.8%MSFT

Analyze MLYS

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MLYS or MSFT a better investment?

Comparing MLYS and MSFT: Mineralys Therapeutics, Inc. Common Stock has a market cap of $2.53B while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MLYS and MSFT?

MLYS (Mineralys Therapeutics, Inc. Common Stock) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MLYS or MSFT?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MLYS or MSFT?

MSFT has higher revenue growth at 14.9% vs 0.0% for MLYS.

Which company is more profitable: MLYS or MSFT?

Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 0.0% for MLYS.

Which is the larger company: MLYS or MSFT?

Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $2.53B for MLYS.

Should I buy MLYS or MSFT in 2026?

Both MLYS and MSFT have investment merit. MLYS trades at $31.93 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MLYS and MSFT stock?

Key differences: Market Cap ($2.53B vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (0.0% vs 68.8%).

Popular Stock Comparisons